kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - kaikki muut terapeuttiset tuotteet - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
tybost
gilead sciences ireland uc - cobicistat - hiv-infektiot - antiviraalit systeemiseen käyttöön - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
venlafaxin hexal 75 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxin hexal 150 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 150 mg - venlafaksiini
venlafaxine bluefish 75 mg depotkapseli, kova
bluefish pharmaceuticals ab bluefish pharmaceuticals ab - venlafaxini hydrochloridum - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxine bluefish 150 mg depotkapseli, kova
bluefish pharmaceuticals ab bluefish pharmaceuticals ab - venlafaxini hydrochloridum - depotkapseli, kova - 150 mg - venlafaksiini
venlafaxin hexal 37.5 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 37.5 mg - venlafaksiini
venlafaxin orion 37.5 mg depotkapseli, kova
orion corporation - venlafaxine hydrochloride - depotkapseli, kova - 37.5 mg - venlafaksiini
venlafaxin orion 75 mg depotkapseli, kova
orion corporation - venlafaxine hydrochloride - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxin orion 150 mg depotkapseli, kova
orion corporation - venlafaxine hydrochloride - depotkapseli, kova - 150 mg - venlafaksiini